1.2  -0.075 (-5.88%)		03-21 16:00
Open: 1.28 High: 1.3 Volume: 2,288,364		Pre. Close: 1.275 Low: 1.145 Market Cap: 87(M)

Short term
Mid term
Targets	6-month :	1.31	1-year :	1.48
Resists	First :	1.12	Second :	1.26
Pivot price	1.08
Supports	First :	0.9	Second :	0.74
MAs	MA(5) :	0.97	MA(20) :	1.05
	MA(100) :	1.75	MA(250) :	3.02
MACD	MACD :	-0.1	Signal :	-0.1
%K %D	K(14,3) :	6.7	D(3) :	13.7
RSI	RSI(14): 37.4
52-week	High :	6.11	Low :	0.9

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ BLI ] has closed above bottom band by 15.6%. Bollinger Bands are 34.6% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

If tomorrow:	Open lower	Open higher
High:	0.99 - 1	1 - 1
Low:	0.9 - 0.91	0.91 - 0.91
Close:	0.93 - 0.95	0.95 - 0.96

Berkeley Lights, Inc., a digital cell biology company, focuses on enabling and accelerating the rapid development and commercialization of biotherapeutics and other cell-based products. The company offers an integrated platform, which comprise of proprietary consumables, including OptoSelect chips and reagent kits, automation systems, and application and workflow software. It serves in North America, the Asia Pacific, and Europe. Berkeley Lights, Inc. was incorporated in 2011 and is headquartered in Emeryville, California.

Tue, 07 May 2024
Have Insiders Been Buying Berkeley Lights, Inc. (NASDAQ:BLI) Shares? - Yahoo Movies UK

Thu, 01 Jun 2023
Berkeley Lights Launches New T Cell Functional Analytics Platform at the 34th Congress of the International Society for ... - Lab Manager Magazine

Tue, 21 Mar 2023
Berkeley Lights Completes Acquisition of IsoPlexis Forming PhenomeX, the Functional Cell Biology Company - PR Newswire

Wed, 04 Jan 2023
Berkeley Lights Generates Further Losses Amid Merger Plan (NASDAQ:BLI) - Seeking Alpha

Wed, 21 Dec 2022
Berkeley Lights to Acquire IsoPlexis, Creating a Premier Functional Cell Biology Company - GlobeNewswire

Wed, 27 Jul 2022
Berkeley Lights and Aanika BioSciences Reach Strategic Partnership Milestone By Identifying A Commercially Viable ... - PR Newswire

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Outperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Outperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Underperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Underperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Outperform

Exchange: NASDAQ
Sector: Healthcare
Industry: Biotechnology
Shares Out	72 (M)
Shares Float	54 (M)
Held by Insiders	15 (%)
Held by Institutions	70.3 (%)
Shares Short	2,970 (K)
Shares Short P.Month	2,990 (K)

EPS	-1.34
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	1.97
Profit Margin	-124.8 %
Operating Margin	-120.3 %
Return on Assets (ttm)	-23.1 %
Return on Equity (ttm)	-56 %
Qtrly Rev. Growth	-23.2 %
Gross Profit (p.s.)	0.74
Sales Per Share	1.08
EBITDA (p.s.)	-1.19
Qtrly Earnings Growth	0 %
Operating Cash Flow	-48 (M)
Levered Free Cash Flow	-18 (M)

PE Ratio	-0.72
PEG Ratio	0
Price to Book value	0.48
Price to Sales	0.86
Price to Cash Flow	-1.44

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.